Lack of integrin α1β1 leads to severe glomerulosclerosis after glomerular injury

被引:88
作者
Chen, XW
Moeckel, G
Morrow, JD
Cosgrove, D
Harris, RC
Fogo, AB
Zent, R
Pozzi, A
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37212 USA
[3] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37212 USA
[4] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37212 USA
[5] Vet Affairs Hosp, Nashville, TN USA
[6] Boys Town Natl Res Hosp, Dept Canc Genet, Omaha, NE 68131 USA
关键词
D O I
10.1016/S0002-9440(10)63326-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Severity of fibrosis after injury is determined by the nature of the injury and host genetic susceptibility. Metabolism of collagen, the major component of fibrotic lesions, is, in part, regulated by integrins. Using a model of glomerular injury by adriamycin, which induces reactive oxygen species (ROS) production, we demonstrated that integrin alpha1-null mice develop more severe glomerulosclerosis than wild-type mice. Moreover, primary alpha1-null mesangial cells produce more ROS both at baseline and after adriamycin treatment. Increased ROS synthesis leads to decreased cell proliferation and increased glomerular collagen IV accumulation that is reversed by antioxidants both in vivo and in vitro. Thus, we have identified integrin alpha1beta1 as a modulator of glomerulosclerosis. in addition, we showed a novel pathway where integrin alpha1beta1 modulates ROS production, which in turn controls collagen turnover and ultimately fibrosis. Because integrin alpha1/beta1 is expressed in many cell types this may represent a generalized mechanism of controlling matrix accumulation, which has implications for numerous diseases characterized by fibrosis.
引用
收藏
页码:617 / 630
页数:14
相关论文
共 38 条
[1]   Redox-mediated activation of latent transforming growth factor-beta 1 [J].
BarcellosHoff, MH ;
Dix, TA .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (09) :1077-1083
[2]   Experimental focal segmental glomerulosclerosis in mice [J].
Chen, A ;
Sheu, LF ;
Ho, YS ;
Lin, YF ;
Chou, WY ;
Chou, TC ;
Lee, WH .
NEPHRON, 1998, 78 (04) :440-452
[3]   Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis [J].
Cook, HT ;
Khan, SB ;
Allen, A ;
Bhangal, G ;
Smith, J ;
Lobb, RR ;
Pusey, CD .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04) :1265-1272
[4]   Integrin α1β1 and transforming growth factor-β1 play distinct roles in Alport glomerular pathogenesis and serve as dual targets for metabolic therapy [J].
Cosgrove, D ;
Rodgers, K ;
Meehan, D ;
Miller, C ;
Bovard, K ;
Gilroy, A ;
Gardner, H ;
Kotelianski, V ;
Gotwals, P ;
Amatucci, A ;
Kalluri, R .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) :1649-1659
[5]   Regulation of inflammation by collagen-binding integrins α1β1 and α2β1 in models of hypersensitivity and arthritis [J].
de Fougerolles, AR ;
Sprague, AG ;
Nickerson-Nutter, CL ;
Chi-Rosso, G ;
Rennert, PD ;
Gardner, H ;
Gotwals, PJ ;
Lobb, RR ;
Koteliansky, VE .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (06) :721-729
[6]   Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis [J].
Deman, A ;
Ceyssens, B ;
Pauwels, M ;
Zhang, JG ;
Vanden Houte, K ;
Verbeelen, D ;
Van den Branden, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (01) :147-150
[7]   Diminished callus size and cartilage synthesis in α1β1 integrin-deficient mice during bone fracture healing [J].
Ekholm, E ;
Hankenson, KD ;
Uusitalo, H ;
Hiltunen, A ;
Gardner, H ;
Heino, J ;
Penttinen, R .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (05) :1779-1785
[8]  
Fogo AB, 1999, EXP NEPHROL, V7, P147
[9]   Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion [J].
Gardner, H ;
Kreidberg, J ;
Koteliansky, V ;
Jaenisch, R .
DEVELOPMENTAL BIOLOGY, 1996, 175 (02) :301-313
[10]  
Gardner H, 1999, J CELL SCI, V112, P263